We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
37 hedge funds and large institutions have $113M invested in Corvus Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
64% more capital invested
Capital invested by funds: $68.9M → $113M (+$44.1M)
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
6% more funds holding
Funds holding: 35 → 37 (+2)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7.23% less ownership
Funds ownership: 77.89% → 70.66% (-7.2%)
50% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 16
Holders
37
Holders Change
+2
Holders Change %
+5.71%
% of All Funds
0.73%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
7
Increased
8
Reduced
16
Closed
5
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
+$16K
Top Buyers
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$4.97M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.32M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.28M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$874K |
| 5 |
Millennium Management
New York
|
-$533K |
